Explain, in your own words (500-750 words), the necessity of using small molecule kinase inhibitors together with antibodies that target EGFR for the possible treatment of colorectal cancer patients. Your answer should be based on the attached paper (1) [within the Folder, “Literature for Seminar-1”]. If you wish, you could also look in paper (2) and other similar articles on PubMed (provided in the “Abstract of the Key Article”).